Home/Filings/4/0001415889-21-001176
4//SEC Filing

Lampropoulos Justin J. 4

Accession 0001415889-21-001176

CIK 0000856982other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 6:28 PM ET

Size

17.3 KB

Accession

0001415889-21-001176

Insider Transaction Report

Form 4
Period: 2021-02-26
Lampropoulos Justin J.
EXEC. V.P. MKTG & STRATEGY
Transactions
  • Award

    Common Stock, No Par Value

    2021-02-26+3,3153,315 total
  • Tax Payment

    Common Stock, No Par Value

    2021-02-26$55.72/sh972$54,1602,343 total
Holdings
  • Non-qualified stock options (right to buy)

    Exercise: $16.05From: 2017-01-28Exp: 2023-01-28Common Stock (20,000 underlying)
    20,000
  • Non-qualified stock options (right to buy)

    Exercise: $28.20From: 2018-04-14Exp: 2024-04-14Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $37.71From: 2021-02-26Exp: 2027-02-26Common Stock (16,722 underlying)
    16,722
  • Non-qualified stock options (right to buy)

    Exercise: $17.27From: 2016-02-13Exp: 2022-02-13Common Stock (20,000 underlying)
    20,000
  • Non-qualified stock options (right to buy)

    Exercise: $55.73From: 2020-03-01Exp: 2026-03-01Common Stock (30,000 underlying)
    30,000
  • Non-qualified stock options (right to buy)

    Exercise: $44.80From: 2019-03-02Exp: 2025-03-02Common Stock (20,000 underlying)
    20,000
  • Non-qualified stock options (right to buy)

    Exercise: $12.06From: 2015-10-04Exp: 2021-10-04Common Stock (5,000 underlying)
    5,000
Footnotes (10)
  • [F1]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020.
  • [F10]Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
  • [F2]Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
  • [F3]The number of securities underlying these stock options was incorrectly reported in the Form 4 filed on 02/28/2020. All previously reported transactions involving these stock options are correct.
  • [F4]The number of securities beneficially owned was incorrectly reported in the Form 4 filed on 02/28/2020. All previously reported transactions involving these stock options are correct.
  • [F5]Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
  • [F6]Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
  • [F7]Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018
  • [F8]Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
  • [F9]Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother

Related Parties

1
  • filerCIK 0001643609

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:28 PM ET
Size
17.3 KB